{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T02:13:34Z","timestamp":1788488014171,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 GM129327"],"award-info":[{"award-number":["R01 GM129327"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R35 GM131710"],"award-info":[{"award-number":["R35 GM131710"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Structural Biology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jsb.2026.108355","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:30:55Z","timestamp":1786663855000},"page":"108355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Structure of an inhibitor bound to the catalytically important divalent metal ion site of afRioK1"],"prefix":"10.1016","volume":"218","author":[{"given":"Daniel A.","family":"Hunter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purushottamachar","family":"Puranik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Pozharski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishat","family":"Seraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dudley","family":"Strickland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanshika","family":"Dave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"LaRonde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Alexander D.","family":"MacKerell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsb.2026.108355_bb0005","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/s42003-025-08343-x","article-title":"Pore formation by the CDTb component of the Clostridioides difficile binary toxin is Ca(2+)-dependent","volume":"8","author":"Abeyawardhane","year":"2025","journal-title":"Commun. Biol."},{"issue":"1\u20133","key":"10.1016\/j.jsb.2026.108355_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-5793(02)02993-9","article-title":"RIO1, an extraordinary novel protein kinase","volume":"524","author":"Angermayr","year":"2002","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.jsb.2026.108355_bb0015","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2958.2002.02881.x","article-title":"Yeast Rio1p is the founding member of a novel subfamily of protein serine kinases involved in the control of cell cycle progression","volume":"44","author":"Angermayr","year":"2002","journal-title":"Mol. Microbiol."},{"issue":"2","key":"10.1016\/j.jsb.2026.108355_bb0020","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00294-018-0912-y","article-title":"The Rio1 protein kinases\/ATPases: conserved regulators of growth, division, and genomic stability","volume":"65","author":"Berto","year":"2019","journal-title":"Curr. Genet."},{"issue":"3","key":"10.1016\/j.jsb.2026.108355_bb0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0026-895X(25)12339-0","article-title":"Comparison of the cellular and RNA-dependent effects of sangivamycin and toyocamycin in human colon carcinoma cells","volume":"27","author":"Cohen","year":"1985","journal-title":"Mol. Pharmacol."},{"issue":"6","key":"10.1016\/j.jsb.2026.108355_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107313","article-title":"SORL1 is a receptor for tau that promotes tau seeding","volume":"300","author":"Cooper","year":"2024","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.jsb.2026.108355_bb0035","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1021\/j100059a038","article-title":"Solvent-induced forces between two hydrophilic groups","volume":"98","author":"Durell","year":"1994","journal-title":"J. Phys. Chem."},{"issue":"12","key":"10.1016\/j.jsb.2026.108355_bb0040","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2174\/0929867003374048","article-title":"Inhibitors of cyclin-dependent kinases as anti-cancer therapeutics","volume":"7","author":"Fischer","year":"2000","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jsb.2026.108355_bb0045","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1039\/D1NJ04028F","article-title":"Application of site-identification by ligand competitive saturation in computer-aided drug design","volume":"46","author":"Goel","year":"2022","journal-title":"New J. Chem."},{"key":"10.1016\/j.jsb.2026.108355_bb0050","doi-asserted-by":"crossref","first-page":"8844","DOI":"10.1039\/D1SC01781K","article-title":"Rapid and accurate estimation of protein-ligand relative binding affinities using site-identification by ligand competitive saturation","volume":"12","author":"Goel","year":"2021","journal-title":"Chem. Sci."},{"issue":"1","key":"10.1016\/j.jsb.2026.108355_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0968-0896(00)00221-2","article-title":"Synthesis and cytotoxicity of 4\u2032-C- and 5\u2032-C-substituted toyocamycins","volume":"9","author":"Gunic","year":"2001","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.jsb.2026.108355_bb0060","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1021\/jo00826a049","article-title":"Pyrrolopyrimidine nucleosides. V. Relative chemical reactivity of the 5-cyano group of the nucleoside antibiotic toyocamycin and desaminotoyocamycin. Synthesis of analogs of sangivamycin","volume":"35","author":"Hinshaw","year":"1970","journal-title":"J. Org. Chem."},{"issue":"1","key":"10.1016\/j.jsb.2026.108355_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nmeth.4067","article-title":"CHARMM36m: an improved force field for folded and intrinsically disordered proteins","volume":"14","author":"Huang","year":"2017","journal-title":"Nat. Methods"},{"issue":"4","key":"10.1016\/j.jsb.2026.108355_bb0070","first-page":"1067","article-title":"Elevated expression of RIOK1 is correlated with breast cancer hormone receptor status and promotes cancer progression","volume":"52","author":"Huang","year":"2020","journal-title":"Cancer Res. Treat."},{"issue":"5","key":"10.1016\/j.jsb.2026.108355_bb0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037371","article-title":"Interaction of Rio1 kinase with toyocamycin reveals a conformational switch that controls oligomeric state and catalytic activity","volume":"7","author":"Kiburu","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.jsb.2026.108355_bb0080","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1021\/ct500201y","article-title":"Sampling of organic solutes in aqueous and heterogeneous environments using oscillating excess chemical potentials in grand canonical-like Monte Carlo-molecular dynamics simulations","volume":"10","author":"Lakkaraju","year":"2014","journal-title":"J. Chem. Theory Comput."},{"issue":"9","key":"10.1016\/j.jsb.2026.108355_bb0085","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1016\/j.str.2004.06.016","article-title":"Crystal structure of A. fulgidus Rio2 defines a new family of serine protein kinases","volume":"12","author":"Laronde-Leblanc","year":"2004","journal-title":"Structure"},{"issue":"1","key":"10.1016\/j.jsb.2026.108355_bb0090","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbapap.2005.07.037","article-title":"The RIO kinases: an atypical protein kinase family required for ribosome biogenesis and cell cycle progression","volume":"1754","author":"LaRonde-LeBlanc","year":"2005","journal-title":"Biochim. Biophy. Acta Proteins Proteomics"},{"issue":"14","key":"10.1016\/j.jsb.2026.108355_bb0095","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1111\/j.1742-4658.2005.04796.x","article-title":"Structure and activity of the atypical serine kinase Rio1","volume":"272","author":"LaRonde-LeBlanc","year":"2005","journal-title":"FEBS J."},{"issue":"10","key":"10.1016\/j.jsb.2026.108355_bb0100","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1007\/s00262-002-0322-2","article-title":"Characterisation of tumour-associated antigens in colon cancer","volume":"51","author":"Line","year":"2002","journal-title":"Cancer Immunol. Immunother."},{"issue":"3","key":"10.1016\/j.jsb.2026.108355_bb0105","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.celrep.2016.03.043","article-title":"MTAP Deletions in cancer create vulnerability to targeting of the MAT2A\/PRMT5\/RIOK1 axis","volume":"15","author":"Marjon","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.jsb.2026.108355_bb0110","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"Appl. Crystallogr."},{"key":"10.1016\/j.jsb.2026.108355_bb0115","series-title":"2024.0601 Chemical Computing Group ULC, 910-1010 Sherbrooke St. W., Montreal, QC H3A 2R7","author":"Molecular Operating Environment (MOE)","year":"2026"},{"issue":"12","key":"10.1016\/j.jsb.2026.108355_bb0120","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.7164\/antibiotics.43.1586","article-title":"Inhibition of phosphatidylinositol kinase by toyocamycin","volume":"43","author":"Nishioka","year":"1990","journal-title":"J. Antibiot."},{"issue":"1","key":"10.1016\/j.jsb.2026.108355_bb0125","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pharep.2016.10.014","article-title":"Toyocamycin induces apoptosis via the crosstalk between reactive oxygen species and p38\/ERK MAPKs signaling pathway in human prostate cancer PC-3 cells","volume":"69","author":"Park","year":"2017","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jsb.2026.108355_bb0130","article-title":"A kinase-dependent checkpoint prevents escape of immature ribosomes into the translating pool","volume":"17","author":"Parker","year":"2022","journal-title":"PLoS Biol."},{"issue":"12","key":"10.1016\/j.jsb.2026.108355_bb0135","doi-asserted-by":"crossref","first-page":"3384","DOI":"10.1021\/ci4005628","article-title":"Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach","volume":"53","author":"Raman","year":"2013","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.jsb.2026.108355_bb0140","doi-asserted-by":"crossref","first-page":"e79","DOI":"10.1038\/bcj.2012.26","article-title":"Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing","volume":"2","author":"Ri","year":"2012","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jsb.2026.108355_bb0150","doi-asserted-by":"crossref","first-page":"12189","DOI":"10.1093\/nar\/gku878","article-title":"Rio1 mediates ATP-dependent final maturation of 40S ribosomal subunits","volume":"42","author":"Turowski","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"16","key":"10.1016\/j.jsb.2026.108355_bb0155","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"issue":"4","key":"10.1016\/j.jsb.2026.108355_bb0160","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/jcc.21367","article-title":"CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields","volume":"31","author":"Vanommeslaeghe","year":"2010","journal-title":"J. Comput. Chem."},{"issue":"15","key":"10.1016\/j.jsb.2026.108355_bb0165","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.1093\/emboj\/20.15.4204","article-title":"Processing of 20S pre-rRNA to 18S ribosomal RNA in yeast requires Rrp10p, an essential non-ribosomal cytoplasmic protein","volume":"20","author":"Vanrobays","year":"2001","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.jsb.2026.108355_bb0170","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1128\/MCB.23.6.2083-2095.2003","article-title":"Late cytoplasmic maturation of the small ribosomal subunit requires RIO proteins in Saccharomyces cerevisiae","volume":"23","author":"Vanrobays","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"13","key":"10.1016\/j.jsb.2026.108355_bb0175","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1021\/jm000035+","article-title":"Synthesis and cytokine modulation properties of Pyrrolo[2,3-d]-4-pyrimidone nucleosides","volume":"43","author":"Wang","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jsb.2026.108355_bb0180","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ebiom.2017.04.015","article-title":"The atypical kinase RIOK1 promotes tumor growth and invasive behavior","volume":"20","author":"Weinberg","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jsb.2026.108355_bb0185","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1091\/mbc.e11-07-0639","article-title":"The kinase activity of human Rio1 is required for final steps of cytoplasmic maturation of 40S subunits","volume":"23","author":"Widmann","year":"2011","journal-title":"Mol. Biol. Cell"},{"issue":"31","key":"10.1016\/j.jsb.2026.108355_bb0190","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1002\/jcc.23067","article-title":"Extension of the CHARMM general force field to sulfonyl-containing compounds and its utility in biomolecular simulations","volume":"33","author":"Yu","year":"2012","journal-title":"J. Comput. Chem."}],"container-title":["Journal of Structural Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047847726000717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1047847726000717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:44:06Z","timestamp":1788486246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1047847726000717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1047847726000717"],"URL":"https:\/\/doi.org\/10.1016\/j.jsb.2026.108355","relation":{},"ISSN":["1047-8477"],"issn-type":[{"value":"1047-8477","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure of an inhibitor bound to the catalytically important divalent metal ion site of afRioK1","name":"articletitle","label":"Article Title"},{"value":"Journal of Structural Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsb.2026.108355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108355"}}